{"title": "Neurolog\u00eda.com", "author": "Viguera Editores", "url": null, "hostname": null, "description": "Neurolog\u00eda.com", "sitename": null, "date": "2023-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Un nuevo estudio confirma que la vacunaci\u00f3n en adultos mayores de 60 a\u00f1os con la vacuna contra el herpes z\u00f3ster redujo los casos de herpes z\u00f3ster en un 50% en comparaci\u00f3n en comparaci\u00f3n con los no vacunados. La investigaci\u00f3n, realizada a partir de datos del Kaiser Permanente Southern California health plan, se publica en la revista Journal of the American Medical Association.\nLos investigadores realizaron un estudio retrospectivo comparando el riesgo de herpes z\u00f3ster entre los 75.761 miembros mayores de 60 a\u00f1os que fueron inmunocompetentes y recibieron la vacuna, con los datos de 227.283 miembros no vacunados de edad similar que no recibieron la vacuna. Se identificaron 5.434 casos de herpes z\u00f3ster, 6,4 casos por 1.000 personas/a\u00f1o entre los vacunados frente a 13,0 casos por 1.000 persona/a\u00f1os entre los no vacunados. En un an\u00e1lisis ajustado, la vacunaci\u00f3n se asoci\u00f3 a la reducci\u00f3n del riesgo en un 55% menor para el herpes z\u00f3ster. La reducci\u00f3n en el riesgo no vari\u00f3 con la edad a la cual se realiz\u00f3 la vacunaci\u00f3n, el sexo, la raza o la presencia de enfermedades cr\u00f3nicas.\nPalabras clave\n[contagio](https://neurologia.com/buscar/contagio/p) [Vacunaci\u00f3n](https://neurologia.com/buscar/vacunacion/p) [virus herpes zoster](https://neurologia.com/buscar/virus+herpes+zoster/p) Categorias [Infecciones](https://neurologia.com/categoria/13n/infecciones) [Neurogeriatr\u00eda](https://neurologia.com/categoria/19n/neurogeriatria)", "language": null, "image": "https://neurologia.com/img/logos/logo_social.jpg", "pagetype": "website", "links": ["https://neurologia.com/", "https://neurologia.com/", "#", "revista", "revista-sociedades", "comite-editorial", "responsabilidades", "gestion/contacta", "gestion/enviar-manuscrito", "basicos", "gestion/estado-articulo", "#", "https://neurologia.com/revista/77/06", "revista", "revista-sociedades", "comite-editorial", "responsabilidades", "gestion/contacta", "gestion/enviar-manuscrito", "basicos", "gestion/estado-articulo", "revisores", "#", "noticias", "podcast", "revista/casos-clinicos", "revista/comunicados-sociedades", "entrevistas", "separatas", "anuncios", "patrocinio", "#", "noticias", "podcast", "revista/casos-clinicos", "revista/comunicados-sociedades", "entrevistas", "separatas", "anuncios", "patrocinio", "agenda", "#", "", "https://www.ineurocampus.com", "https://www.ineurocampus.com/master-en-trastornos-del-movimiento.html", "https://www.ineurocampus.com/master-en-neurociencia-experimental-y-clinica.html", "https://www.ineurocampus.com/master-en-neuroinmunologia.html", "https://www.ineurocampus.com/master-en-sueno-fisiologia-y-medicina.html", "https://www.ineurocampus.com/master-en-epilepsia.html", "https://www.ineurocampus.com/master-en-neuropsicologia-de-las-altas-capacidades-intelectuales.html", "https://www.ineurocampus.com/master-en-trastornos-del-espectro-autista.html", "https://www.ineurocampus.com/master-en-psicobiologia-y-neurociencia-cognitiva.html", "#", "", "https://www.ineurocampus.com", "https://www.ineurocampus.com/master-en-trastornos-del-movimiento.html", "https://www.ineurocampus.com/master-en-neurociencia-experimental-y-clinica.html", "https://www.ineurocampus.com/master-en-neuroinmunologia.html", "https://www.ineurocampus.com/master-en-sueno-fisiologia-y-medicina.html", "https://www.ineurocampus.com/master-en-epilepsia.html", "https://www.ineurocampus.com/master-en-neuropsicologia-de-las-altas-capacidades-intelectuales.html", "https://www.ineurocampus.com/master-en-trastornos-del-espectro-autista.html", "https://www.ineurocampus.com/master-en-psicobiologia-y-neurociencia-cognitiva.html", "#", null, "", "http://jama.ama-assn.org/content/305/2/160.short ", "https://www.facebook.com/sharer/sharer.php?u=noticia/2623/la-vacunacion-reduce-a-la-mitad-los-casos-de-herpes-zoster", "https://twitter.com/intent/tweet?url=noticia/2623/la-vacunacion-reduce-a-la-mitad-los-casos-de-herpes-zoster&text=La vacunaci\u00f3n reduce a la mitad los casos de herpes z\u00f3ster", "https://neurologia.com/buscar/contagio/p", "https://neurologia.com/buscar/vacunacion/p", "https://neurologia.com/buscar/virus+herpes+zoster/p", "https://neurologia.com/categoria/13n/infecciones", "https://neurologia.com/categoria/19n/neurogeriatria", "gestion/enviar-manuscrito", "comite-editorial", "revista-sociedades", null, "https://ineurocampus.com/master/149/master-en-neuroinmunologia.html", "https://ineurocampus.com/master/145/master-de-formacion-permanente-en-trastornos-del-espectro-autista.html", "https://ineurocampus.com/master/152/master-de-formacion-permanente-en-neuroderecho-penal.html", "https://ineurocampus.com/master/146/master-de-formacion-permanente-en-neuropsicologia-de-las-altas-capacidades-intelectuales.html", "https://www.viguera.com/", "https://www.evidenze.com/", "https://ineurocampus.com/", "//stamp.wma.comb.es/es/seal/2735", "politica-privacidad", "aviso-legal", "cookies", "https://neurologia.com/", "revista", "agenda", "formacion", "https://www.linkedin.com/company/viguera", "https://twitter.com/RevNeurol", "https://www.facebook.com/RevNeurol", "https://wa.me/0034686590906", "https://t.me/Viguera_Editores"]}